Who makes Intravenous Ephedrine Bolus?

Intravenous Ephedrine Bolus is developed by Mansoura University.

What development phase is Intravenous Ephedrine Bolus in?

Intravenous Ephedrine Bolus is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Intravenous Ephedrine Bolus

Mansoura University · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Intravenous Ephedrine Bolus
Sponsor	Mansoura University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine (PHASE4)
Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery (PHASE3)
The Noninvasive Blood Pressure Measurement Effect on the Hypotension (NA)
Effect of Ephedrine vs. Norepinephrine on Prevention of Fetal Acidosis During Cesarean Section Under Spinal Anesthesia (PHASE4)
Intravenous Administration of Magnesium Sulfate in Laparoscopic Hysterectomy Cases (NA)
HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients Undergoing Major Abdominal Surgery (NA)
Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases (NA)
Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Intravenous Ephedrine Bolus CI brief — competitive landscape report
Intravenous Ephedrine Bolus updates RSS · CI watch RSS
Mansoura University portfolio CI